Zurich Cantonal Bank’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.25M | Sell |
60,185
-5,955
| -9% | -$322K | 0.01% | 754 |
|
|
2026
Q1 | $3.46M | Buy |
66,140
+21,175
| +47% | +$1.27M | 0.01% | 783 |
|
|
2025
Q4 | $2.64M | Buy |
44,965
+11,232
| +33% | +$682K | 0.01% | 833 |
|
|
2025
Q3 | $1.88M | Buy |
33,733
+2,171
| +7% | +$116K | ﹤0.01% | 947 |
|
|
2025
Q2 | $1.62M | Sell |
31,562
-2,443
| -7% | -$123K | ﹤0.01% | 966 |
|
|
2025
Q1 | $1.99M | Buy |
34,005
+249
| +0.7% | +$16.9K | 0.01% | 825 |
|
|
2024
Q4 | $2.43M | Sell |
33,756
-979
| -3% | -$71.9K | 0.01% | 774 |
|
|
2024
Q3 | $2.78M | Buy |
34,735
+6,462
| +23% | +$486K | 0.01% | 710 |
|
|
2024
Q2 | $2.03M | Buy |
28,273
+482
| +2% | +$35.5K | 0.01% | 751 |
|
|
2024
Q1 | $1.96M | Sell |
27,791
-247
| -0.9% | -$17.7K | 0.01% | 768 |
|
|
2023
Q4 | $2.16M | Buy |
28,038
+3,559
| +15% | +$234K | 0.01% | 717 |
|
|
2023
Q3 | $1.67M | Buy |
24,479
+1,644
| +7% | +$130K | 0.01% | 761 |
|
|
2023
Q2 | $1.86M | Buy |
22,835
+563
| +3% | +$45.3K | 0.01% | 726 |
|
|
2023
Q1 | $1.65M | Hold |
22,272
| – | – | 0.01% | 733 |
|
|
2022
Q4 | $1.85M | Sell |
22,272
-60
| -0.3% | -$4.76K | 0.01% | 690 |
|
|
2022
Q3 | $1.59M | Buy |
22,332
+2,260
| +11% | +$195K | 0.01% | 724 |
|
|
2022
Q2 | $1.74M | Sell |
20,072
-13,916
| -41% | -$1.3M | 0.01% | 706 |
|
|
2022
Q1 | $3.68M | Hold |
33,988
| – | – | 0.02% | 586 |
|
|
2021
Q4 | $4.4M | Sell |
33,988
-2,384
| -7% | -$292K | 0.02% | 572 |
|
|
2021
Q3 | $4.41M | Buy |
36,372
+436
| +1% | +$53.1K | 0.02% | 552 |
|
|
2021
Q2 | $4.04M | Buy |
35,936
+20,288
| +130% | +$2.14M | 0.02% | 540 |
|
|
2021
Q1 | $1.49M | Sell |
15,648
-2,736
| -15% | -$250K | 0.01% | 769 |
|
|
2020
Q4 | $1.46M | Buy |
18,384
+856
| +5% | +$62K | 0.01% | 829 |
|
|
2020
Q3 | $1.09M | Buy |
17,528
+816
| +5% | +$53.1K | 0.01% | 829 |
|
|
2020
Q2 | $1.1M | Buy |
16,712
+3,632
| +28% | +$218K | 0.01% | 772 |
|
|
2020
Q1 | $620K | Buy |
13,080
+2,592
| +25% | +$130K | 0.01% | 837 |
|
|
2019
Q4 | $576K | Buy |
10,488
+1,236
| +13% | +$64.8K | ﹤0.01% | 892 |
|
|
2019
Q3 | $453K | Hold |
9,252
| – | – | ﹤0.01% | 927 |
|
|
2019
Q2 | $482K | Buy |
9,252
+424
| +5% | +$21.4K | ﹤0.01% | 922 |
|
|
2019
Q1 | $438K | Sell |
8,828
-1,608
| -15% | -$72.4K | ﹤0.01% | 916 |
|
|
2018
Q4 | $378K | Buy |
10,436
+952
| +10% | +$39.8K | ﹤0.01% | 957 |
|
|
2018
Q3 | $484K | Buy |
9,484
+500
| +6% | +$22.1K | ﹤0.01% | 935 |
|
|
2018
Q2 | $332K | Sell |
8,984
-1,664
| -16% | -$63.5K | ﹤0.01% | 1014 |
|
|
2018
Q1 | $402K | Buy |
10,648
+2,372
| +29% | +$83.8K | ﹤0.01% | 915 |
|
|
2017
Q4 | $268K | Buy |
8,276
+2,452
| +42% | +$77.9K | ﹤0.01% | 1037 |
|
|
2017
Q3 | $176K | Hold |
5,824
| – | – | ﹤0.01% | 1073 |
|
|
2017
Q2 | $171K | Buy |
5,824
+652
| +13% | +$17.8K | ﹤0.01% | 1069 |
|
|
2017
Q1 | $131K | Hold |
5,172
| – | – | ﹤0.01% | 1178 |
|
|
2016
Q4 | $133K | Hold |
5,172
| – | – | ﹤0.01% | 1134 |
|
|
2016
Q3 | $142K | Buy |
5,172
+612
| +13% | +$16.8K | ﹤0.01% | 1051 |
|
|
2016
Q2 | $129K | Hold |
4,560
| – | – | ﹤0.01% | 1032 |
|
|
2016
Q1 | $108K | Hold |
4,560
| – | – | ﹤0.01% | 1089 |
|
|
2015
Q4 | $103K | Buy |
4,560
+2,620
| +135% | +$59.7K | ﹤0.01% | 1123 |
|
|
2015
Q3 | $45K | Buy |
1,940
+1,192
| +159% | +$29.9K | ﹤0.01% | 1146 |
|
|
2015
Q2 | $18K | Hold |
748
| – | – | ﹤0.01% | 1134 |
|
|
2015
Q1 | $19K | Buy |
+748
| New | +$17.8K | ﹤0.01% | 1118 |
|
Other funds holding TECH
HI
Zurich Cantonal Bank's TECH Position: Q2 2026 in Review
Zurich Cantonal Bank reduced its Bio-Techne (TECH) stake by 9% in Q2 2026, selling an estimated $322K and leaving 60,185 shares worth $4.25M. The position accounts for 0.01% of the portfolio, ranked #754.
Zurich Cantonal Bank first reported a position in TECH in Q1 2015 and has held it in 46 quarters since. The position peaked at $4.41M in Q3 2021. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Zurich Cantonal Bank held 60,185 shares of Bio-Techne worth $4.25M as of Q2 2026.
- Zurich Cantonal Bank sold 5,955 Bio-Techne shares in Q2 2026, an estimated $322K.
- Bio-Techne made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #754 holding.
- Zurich Cantonal Bank first reported a position in Bio-Techne in Q1 2015 and has held it in 46 quarters since.
- Zurich Cantonal Bank's Bio-Techne position peaked at $4.41M in Q3 2021.
- 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.